Holen Sie sich die Stockscreener-App
1.04
5.48%
0.054
Handel nachbörslich:
1.05
0.01
+0.96%
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Price to sales ratio of Inovio Pharmaceuticals, Inc. – HAN:GBM - TradingView
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals (INO) Short Interest & Short Float | Updated Oct 2026 $INO - MarketBeat
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer - Zacks Investment Research
Inovio Pharmaceuticals (INO) Institutional Ownership 2026 $INO - MarketBeat
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Updates Bylaws with New Exclusive-Forum Provision - The Globe and Mail
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio advances FDA review: Inovio Pharmaceuticals stock falls 3.77 percent - AD HOC NEWS
Inovio Pharmaceuticals stock fell 4.13 percent before FDA decision - AD HOC NEWS
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals stock approaches its October FDA test - AD HOC NEWS
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - Zacks Investment Research
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care - GlobeNewswire Inc.
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Debt to equity ratio of Inovio Pharmaceuticals, Inc. – HAN:GBM - TradingView
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Pharmaceuticals stock trades lower as FDA date nears - AD HOC NEWS
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals stock gains as price crosses 200-day moving average - AD HOC NEWS
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals stock trades near 52-week midpoint as analysts keep Moderate Buy view - AD HOC NEWS
Inovio at H.C. Wainwright conference: FDA review and launch loom By Investing.com - Investing.com South Africa
Inovio at H.C. Wainwright conference: FDA review and launch loom By Investing.com - Investing.com Nigeria
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms - TradingView
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms - Yahoo Finance
Inovio at H.C. Wainwright conference: FDA review and launch loom By Investing.com - Investing.com India
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP - TradingView
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP - Yahoo Finance
INOVIO at Cantor Fitzgerald healthcare conference: FDA decision nears By Investing.com - Investing.com India
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INOVIO Steps Up Investor Outreach at New York Conferences - MyChesCo
INO Stockholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INOVIO to Participate in Upcoming Investor Conferences - Eastern Progress
Inovio Pharmaceuticals Stock Price Forecast. Should You Buy INO? - StockInvest.us
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals stock gains as analysts see sharp upside - ad-hoc-news.de
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Investor talks begin Sept. 9 as INOVIO joins two conferences - Stock Titan
INOVIO to Participate in Upcoming Investor Conferences - PR Newswire
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):